© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 11, 913-915,
June 2, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The 1999 General Motors Foundation laureates will receive their awards June 9 at a ceremony at the U.S. Department of State following the foundation's annual scientific conference. This year's conference on June 8 and 9 will once again be held at the National Institutes of Health. The award recipients this year are:Arnold J. Levine, Ph.D., will receive the Charles S. Mott Prize for cancer prevention for "the isolation, cloning, and characterization of the biological properties of the p53 tumor suppressor gene." Levine is president of Rockefeller University, New York.
|
Ronald Levy, M.D., will receive the Charles F. Kettering Prize for cancer treatment for "demonstrating that the administration of monoclonal antibodies can produce objective clinical responses in patients with B cell lymphomas." Levy is professor and chief of the Division of Oncology at Stanford University, Palo Alto, Calif.
Robert G. Roeder, Ph.D., and Robert Tjian, Ph.D., will share the Alfred P. Sloan Prize for basic research for "their discoveries on the mechanism and regulation of gene transcription in eukaryotic cells."
Each of the three prizes includes an award of $250,000.
National Medals
President Clinton presented National Medals of Science, the nation's highest scientific honor, to nine individuals, and National Medals of Engineering, awarded for technological breakthroughs, to seven individuals and two companies.
Among those who received the National Medal of Science were Bruce N. Ames, Ph.D., "for changing the direction of basic and applied research on mutation, cancer, and aging;" and Janet D. Rowley, M.D., for "revolutionizing cancer research, diagnosis, and treatment through her discovery of chromosomal translocations in cancer and for her pioneering work on the relationship of prior treatment to recurring chromosome abnormalities."
|
|
Ames is professor of biochemistry and molecular biology at the University of California, Berkeley, and Rowley is a professor at the University of Chicago. Both are former members of the National Cancer Advisory Board.
Among those receiving the National Medal of Technology was Biogen, Inc., Cambridge, Mass., "for its leadership in applying breakthroughs in biology to the development of lifesaving and life-enhancing pharmaceutical products . . . and for the development of hepatitis B vaccines, the first vaccines using recombinant DNA technology."
Another of the medals went to Bristol-Myers Squibb Co., New York, "for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study . . ."
RPCI Honors Piver
The Roswell Park Cancer Institute, Buffalo, recently established the M. Steven Piver Distinguished Service Chair in Gynecologic Oncology, the first endowed chairmanship in the 100 years of the institute, in honor of the work of M. Steven Piver, M.D., as chair of the RPCI Department of Gynecologic Oncology.
|
The announcement said that the new endowment will support basic and clinical research and educational initiatives in gynecologic oncology, underwrite the Gilda Radner Familial Ovarian Cancer Registry and the institute's toll-free ovarian hotline, and help recruit and retain clinicians, researchers, and teachers.
ASBMT Awards
The American Society for Blood and Marrow Transplantation, Arlington Heights, Ill., presented its annual Public Service Award to retired naval Admiral Elmo R. Zumwalt, Jr., acknowledging his contributions to medical care and research that benefited bone marrow transplant patients and their families.
Rainer F. Storb, M.D., presented the annual E. Donnall Thomas Lecture at the ASMBT annual meeting. Storb is head of transplantation biology at the Fred Hutchinson Cancer Research Center, Seattle.
Australia Honors Withers
Australia presented one of its highest honors to H. Rodney Withers, M.D., to recognize his lifetime achievements in radiation oncology. Withers, a native Australian who now chairs radiation oncology at UCLA School of Medicine, was appointed as an officer in the Order of Australia's General Division.
The announcement said that an appointment in the Order of Australia is the equivalent of a British knighthood. The award citation lauded Withers for "his establishment of a scientific basis for clinical trials related to side effects and tumor control by radiation treatment."
DiGiovanni Heads Science Park
The University of Texas M. D. Anderson Cancer Center, Houston, named John DiGiovanni, Ph.D., director of its Science Park-Research Division in Smithville, Tex., and chairman of the Department of Carcinogenesis. He also directs the Science Park's Center for Research on Environmental Disease.
DiGiovanni has been with the Science Park-Research Division since 1983 and has held the Ruth and Walter Sterling Professorship since 1997.
Stephens Named
Genaissance Pharmaceuticals, Inc., New Haven, Conn., named Joel Claiborne Stephens, Ph.D., as director of population genomics.
Stephens had been head of the Bioinformatics Group at the National Cancer Institute's Laboratory of Genomic Diversity, and at Genaissance he will continue his work in bioinformatics and algorithm models for the analysis of gene variation, the announcement said.
Unilever Chair Established
The Cancer Institute of New Jersey, New Brunswick, announced the establishment of the Unilever Chair for the Study of Diet and Nutrition in the Prevention of Chronic Disease and called for nominations of "recognized experts in nutrition research" for possible appointment to the chair.
Nominations should be submitted to William N. Hait, M.D., Ph.D., chair of the search committee, UMDNJ-Robert Wood Johnson Medical School, Cancer Institute of New Jersey, 195 Little Albany St., New Brunswick, NJ 08901.
Outcomes Research Program
The Coleman Foundation, Inc., awarded a 5-year, $1 million grant to Northwestern University's Robert H. Lurie Comprehensive Cancer Center to develop a health care policy and outcomes research program.
Plans call for the program to focus on three areas: quality of care and patient decision making for breast and ovarian cancer populations; impact of low literacy in cancer screening and treatment; and long-term survival issues for pediatric cancer patients. Charles Bennett, M.D., Ph.D., and David Cella, Ph.D., will develop the program.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||